Study medicine to treat common, plantar, or flat warts
Part of Infections, Skin clinical trials.
This trial tests two versions of an at-home medicine to see how well they clear warts. Participants are randomly assigned to the study medicine or a placebo (inactive treatment) so researchers can compare results fairly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) are age 3 or older and can follow study instructions
- You have warts such as common warts, plantar warts, and/or flat warts
- You must be able to understand and follow visits and follow-up for the full study
- You must not have had any wart-healing treatment in the last 2 months
- You must not have used homeopathic treatment for warts in the last 2 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.
This study tests two treatments for common warts: a sclerotherapy injection and a candida antigen injection. The goal is to see which one works better to remove warts.
This Phase 3 trial tests a nonavalent HPV vaccine to treat long-lasting, hard-to-treat warts on the hands or feet. If you have tried standard treatments and the warts keep coming back or cause trouble, the vaccine may help your body clear the warts.
This study is testing an ointment called tirbanibulin to treat warts on the hands of children and teens. It may offer a new option if other treatments haven't worked.
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
This study tests a new injection-based treatment for common warts (the bumpy growths on skin caused by a virus). Researchers want to see if this approach works better than current options and is safe for patients.
Hear when a new Common Wart trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.